These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 28842845

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Trimethylamine-N-oxide: a link between the gut microbiome, bile acid metabolism, and atherosclerosis.
    Wilson A, McLean C, Kim RB.
    Curr Opin Lipidol; 2016 Apr; 27(2):148-54. PubMed ID: 26959704
    [Abstract] [Full Text] [Related]

  • 4. Gut Microbiota and Cardiovascular Disease.
    Witkowski M, Weeks TL, Hazen SL.
    Circ Res; 2020 Jul 31; 127(4):553-570. PubMed ID: 32762536
    [Abstract] [Full Text] [Related]

  • 5. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide.
    Zhu Y, Li Q, Jiang H.
    APMIS; 2020 May 31; 128(5):353-366. PubMed ID: 32108960
    [Abstract] [Full Text] [Related]

  • 6. Role of gut microbiota in atherosclerosis.
    Jonsson AL, Bäckhed F.
    Nat Rev Cardiol; 2017 Feb 31; 14(2):79-87. PubMed ID: 27905479
    [Abstract] [Full Text] [Related]

  • 7. Dietary lipids, gut microbiota and lipid metabolism.
    Schoeler M, Caesar R.
    Rev Endocr Metab Disord; 2019 Dec 31; 20(4):461-472. PubMed ID: 31707624
    [Abstract] [Full Text] [Related]

  • 8. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.
    Koeth RA, Lam-Galvez BR, Kirsop J, Wang Z, Levison BS, Gu X, Copeland MF, Bartlett D, Cody DB, Dai HJ, Culley MK, Li XS, Fu X, Wu Y, Li L, DiDonato JA, Tang WHW, Garcia-Garcia JC, Hazen SL.
    J Clin Invest; 2019 Jan 02; 129(1):373-387. PubMed ID: 30530985
    [Abstract] [Full Text] [Related]

  • 9. Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis.
    Yeh CF, Chen YH, Liu SF, Kao HL, Wu MS, Yang KC, Wu WK.
    Int J Mol Sci; 2020 Nov 19; 21(22):. PubMed ID: 33227973
    [Abstract] [Full Text] [Related]

  • 10. Trimethylamine N-Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function.
    Canyelles M, Tondo M, Cedó L, Farràs M, Escolà-Gil JC, Blanco-Vaca F.
    Int J Mol Sci; 2018 Oct 19; 19(10):. PubMed ID: 30347638
    [Abstract] [Full Text] [Related]

  • 11. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
    Romano KA, Vivas EI, Amador-Noguez D, Rey FE.
    mBio; 2015 Mar 17; 6(2):e02481. PubMed ID: 25784704
    [Abstract] [Full Text] [Related]

  • 12. Amelioration of TMAO through probiotics and its potential role in atherosclerosis.
    Din AU, Hassan A, Zhu Y, Yin T, Gregersen H, Wang G.
    Appl Microbiol Biotechnol; 2019 Dec 17; 103(23-24):9217-9228. PubMed ID: 31655880
    [Abstract] [Full Text] [Related]

  • 13. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO.
    Koeth RA, Levison BS, Culley MK, Buffa JA, Wang Z, Gregory JC, Org E, Wu Y, Li L, Smith JD, Tang WHW, DiDonato JA, Lusis AJ, Hazen SL.
    Cell Metab; 2014 Nov 04; 20(5):799-812. PubMed ID: 25440057
    [Abstract] [Full Text] [Related]

  • 14. A Multi-omic Association Study of Trimethylamine N-Oxide.
    Manor O, Zubair N, Conomos MP, Xu X, Rohwer JE, Krafft CE, Lovejoy JC, Magis AT.
    Cell Rep; 2018 Jul 24; 24(4):935-946. PubMed ID: 30044989
    [Abstract] [Full Text] [Related]

  • 15. Gut Microbiota, Atherosclerosis, and Therapeutic Targets.
    Mantziaris V, Kolios G.
    Crit Pathw Cardiol; 2019 Sep 24; 18(3):139-142. PubMed ID: 31348074
    [Abstract] [Full Text] [Related]

  • 16. Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis.
    Liu Y, Dai M.
    Mediators Inflamm; 2020 Sep 24; 2020():4634172. PubMed ID: 32148438
    [Abstract] [Full Text] [Related]

  • 17. Oolong Tea Extract and Citrus Peel Polymethoxyflavones Reduce Transformation of l-Carnitine to Trimethylamine-N-Oxide and Decrease Vascular Inflammation in l-Carnitine Feeding Mice.
    Chen PY, Li S, Koh YC, Wu JC, Yang MJ, Ho CT, Pan MH.
    J Agric Food Chem; 2019 Jul 17; 67(28):7869-7879. PubMed ID: 31287296
    [Abstract] [Full Text] [Related]

  • 18. Ligustrum robustum Alleviates Atherosclerosis by Decreasing Serum TMAO, Modulating Gut Microbiota, and Decreasing Bile Acid and Cholesterol Absorption in Mice.
    Liu S, He F, Zheng T, Wan S, Chen J, Yang F, Xu X, Pei X.
    Mol Nutr Food Res; 2021 Jul 17; 65(14):e2100014. PubMed ID: 34005835
    [Abstract] [Full Text] [Related]

  • 19. Microbiome, trimethylamine N-oxide, and cardiometabolic disease.
    Tang WH, Hazen SL.
    Transl Res; 2017 Jan 17; 179():108-115. PubMed ID: 27490453
    [Abstract] [Full Text] [Related]

  • 20. Dietary betaine reduces liver lipid accumulation via improvement of bile acid and trimethylamine-N-oxide metabolism in blunt-snout bream.
    Wang F, Xu J, Jakovlić I, Wang WM, Zhao YH.
    Food Funct; 2019 Oct 16; 10(10):6675-6689. PubMed ID: 31559407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.